Seigo KINUYA*1,*2, Keiichiro YOSHINAGA*1,*3, Tetsuya HIGUCHI*1,*4, Megumi JINGUJI*1,*5, Hiroshi KAWAMOTO*1,*6, Hiroaki KURIHARA*1,*7
*1Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine, *2Department of Nuclear Medicine, Faculty of Medicine, Institutes of Medical, Pharmaceutical and Health Science, Kanazawa University, *3Department of Molecular Imaging, Hokkaido University Graduate School of Medicine, *4Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, *5Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, *6Department of Pediatric Oncology, National Cancer Research Institute, *7Department of Radiology, National Cancer Research Institute
The Japanese Journal of nuclear medicine 52(1): 1-48, 2015.